CBN cookies at a store in Shibuya on Thursday | JESSICA SPEED
Japan’s health ministry announced Wednesday that it has classified cannabinol (CBN), a compound derived from cannabis, as a “designated drug,” banning its manufacture, import, sale and use starting June 1, except for limited medical purposes.
Under the revised ordinance, CBN products — sold domestically both at in-person stores and online as gummies, cookies, oils and vapes — will effectively disappear from the consumer market.
Only patients with specific conditions, such as intractable diseases with no alternative treatment, will be allowed to use them.
In a time of both misinformation and too much information,
quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.